A 'quiet round trip' defensive play; use as a panic signal/temporary trade, not a long-term hold.

A consumer staples stock down 28% due to a combination of tariff impacts and consumer pullback.

The market reacted very negatively (stock fell 15%) to its acquisition of Kenvue due to concerns about taking on significant and unpredictable legal liabilities associated with Kenvue's products.

Reportedly acquiring Kenvue for $40 billion, showing strong confidence in the Tylenol brand. Investors are cautioned to analyze how this large, debt-financed acquisition could impact the company's balance sheet.